These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 26400332)

  • 1. Relationship between serum adiponectin and osteoprotegerin levels and coronary heart disease severity.
    Zhang HL; Jin X
    Genet Mol Res; 2015 Sep; 14(3):11023-9. PubMed ID: 26400332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma level of adiponectin in coronary heart disease patients combined with abnormal glucose metabolism].
    Xia K; Guo L; Zhao Z; Md Sayed AS; Li F; Yang T
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Feb; 37(2):179-84. PubMed ID: 22561436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population.
    Gannagé-Yared MH; Fares F; Semaan M; Khalife S; Jambart S
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):652-8. PubMed ID: 16712667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects.
    Ashley DT; O'Sullivan EP; Davenport C; Devlin N; Crowley RK; McCaffrey N; Moyna NM; Smith D; O'Gorman DJ
    Metabolism; 2011 Jul; 60(7):994-1000. PubMed ID: 21087777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum IMA and LP-PLA2 Levels in Patients with Coronary Heart Disease and Their Correlation with the Degree of Myocardial Ischaemia and Their Diagnostic Value.
    Zhang L; Li Z; Li N
    Emerg Med Int; 2022; 2022():1698315. PubMed ID: 35726302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum osteoprotegerin in relation to metabolic status, severity, and estimated risk of subsequent coronary heart disease.
    Esteghamati A; Sheikhbahaei S; Hafezi-Nejad N; Mousavizadeh M; Noshad S; Gilani Larimi N; Azizi R; Nakhjavani M
    Arch Iran Med; 2014 Sep; 17(9):596-601. PubMed ID: 25204474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of serum lipoprotein-associated phospholipase A2, ischemia-modified albumin, and cystatin C in predicting coronary heart disease risk: a single center retrospective cohort study.
    Le QF; Liu J; Chen L
    Eur Rev Med Pharmacol Sci; 2023 Nov; 27(21):10730-10735. PubMed ID: 37975398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation between the inflammatory factors and adipocytokines with gestational diabetes mellitus and their change in puerperium].
    Liu T; Fang Z; Yang D; Liu Q
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):436-9. PubMed ID: 22932110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of hypoadiponectinemia in men with early onset of coronary heart disease and multiple coronary artery stenoses.
    Hashimoto N; Kanda J; Nakamura T; Horie A; Kurosawa H; Hashimoto T; Sato K; Kushida S; Suzuki M; Yano S; Iwai R; Takahashi H; Yoshida S
    Metabolism; 2006 Dec; 55(12):1653-7. PubMed ID: 17142139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of Serum CysC, IMA, and LP-PLA2 Levels With Type 2 Diabetes Mellitus Patients With Lower Extremity Atherosclerotic Occlusive Disease.
    Feng F; Chen Y; Wang G; Huang P; Zhu Q; Zhou B
    Front Surg; 2022; 9():846470. PubMed ID: 35356504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of osteoprotegerin, sRANKL, inflammatory factors and epicardial adipose tissue volume with coronary heart disease.
    He Q; Ming D; Chen D; Zhang C; Xie H; Wei S
    Int J Clin Pract; 2021 Jul; 75(7):e14207. PubMed ID: 33813793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemia-modified albumin in stable coronary atherosclerotic heart disease: clinical diagnosis and risk stratification.
    Zhong Y; Wang N; Xu H; Hou X; Xu P; Zhou Z
    Coron Artery Dis; 2012 Dec; 23(8):538-41. PubMed ID: 22936021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between bone, fat tissue and metabolic control in children and adolescents with type 1 diabetes mellitus.
    Wędrychowicz A; Stec M; Sztefko K; Starzyk JB
    Exp Clin Endocrinol Diabetes; 2014 Sep; 122(8):491-5. PubMed ID: 24918536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers.
    Rothenbacher D; Brenner H; März W; Koenig W
    Eur Heart J; 2005 Aug; 26(16):1640-6. PubMed ID: 15932907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The correlation of human serum Lp-PLA2 and hs-CRP and stability of coronary atherosclerotic plaques].
    Xu DL; Liu JN; Du YM; Yao GH; Jiang WD; Wang X; Dong ZQ; Hao L; Wang GY; Sui SJ; Li JF; Lu QH
    Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):651-4. PubMed ID: 19954057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin and coronary heart disease: a prospective study and meta-analysis.
    Sattar N; Wannamethee G; Sarwar N; Tchernova J; Cherry L; Wallace AM; Danesh J; Whincup PH
    Circulation; 2006 Aug; 114(7):623-9. PubMed ID: 16894037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoprotegerin and nuclear factor-kappaB ligand are associated with leptin and adiponectin levels, in apparently healthy women.
    Tenta R; Panagiotakos DB; Fragopoulou E; Nomikos T; Pitsavos C; Chrysohoou C; Antonopoulou S; Stefanadis C
    J Musculoskelet Neuronal Interact; 2010 Jun; 10(2):174-9. PubMed ID: 20516635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum adiponectin in patients with coronary heart disease.
    Parul SS; Mazumder M; Debnath BC; Haque ME
    Mymensingh Med J; 2011 Jan; 20(1):78-82. PubMed ID: 21240167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lipoprotein-associated phospholipase A2 on arginase/nitric oxide pathway in hemodialysis patients.
    Tektaş AK; Uslu S; Yalçin AU; Sahin G; Temiz G; Kara M; Temel HE; Demirkan ES; Colak E; Colak O
    Ren Fail; 2012; 34(6):738-43. PubMed ID: 22583316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.